-
My Account
In App
My Account
BSE Live
Oct 24, 16:01Prev. Close
1189.95
Open Price
1166.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Titan Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 24.37 | 31.53 | 28.12 | 38.20 | 42.71 | |
| Net CashFlow From Operating Activities | 20.12 | 21.15 | 21.18 | 22.86 | 19.24 | |
| Net Cash Used In Investing Activities | -9.87 | -20.30 | -20.73 | -18.78 | -8.08 | |
| Net Cash Used From Financing Activities | -7.96 | -2.87 | -2.40 | 6.08 | -7.54 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2.29 | -2.02 | -1.95 | 10.16 | 3.62 | |
| Cash And Cash Equivalents Begin of Year | 2.84 | 4.86 | 6.81 | 5.45 | 1.83 | |
| Cash And Cash Equivalents End Of Year | 5.13 | 2.84 | 4.86 | 15.61 | 5.45 |
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017
